Reinforcement biases subsequent perceptual decisions when confidence is low: a widespread behavioral phenomenon
- University of Oxford, United Kingdom
- MIT, United States
- Doshisha University, Japan
- Cold Spring Harbor Laboratory, United States
- University Medical Center Hamburg-Eppendorf, Germany
- University College London, United Kingdom
- Massachusetts Institute of Technology, United States
- Harvard University, United States
Abstract
Learning from successes and failures often improves the quality of subsequent decisions. Past outcomes, however, should not influence purely perceptual decisions after task acquisition is complete since these are designed so that only sensory evidence determines the correct choice. Yet, numerous studies report that outcomes can bias perceptual decisions, causing spurious changes in choice behavior without improving accuracy. Here we show that the effects of reward on perceptual decisions are principled: past rewards bias future choices specifically when previous choice was difficult and hence decision confidence was low. We identified this phenomenon in six datasets from four laboratories, across mice, rats, and humans, and sensory modalities from olfaction and audition to vision. We show that this choice-updating strategy can be explained by reinforcement learning models incorporating statistical decision confidence into their teaching signals. Thus, despite being suboptimal from the experimenter’s perspective, confidence-guided reinforcement learning optimizes behavior in uncertain, real-world situations.
Data availability
The data used in this study is available at http://dx.doi.org/10.6084/m9.figshare.4300043
Article and author information
Author details
Funding
Wellcome (106101)
- Armin Lak
Wellcome (213465)
- Armin Lak
National Institutes of Health (R01 MH110404)
- Naoshige Uchida
National Institutes of Health (R01MH097061 and R01DA038209)
- Naoshige Uchida
Wellcome (205093)
- Matteo Carandini
Deutsche Forschungsgemeinschaft (DO 1240/2-1 and DO 1240/3-1)
- Tobias H Donner
RIKEN-CBS
- Emily Hueske
- Susumu Tonegawa
JPB Foundation
- Emily Hueske
- Susumu Tonegawa
Howard Hughes Medical Institute
- Emily Hueske
- Susumu Tonegawa
German Academic Exchange Service
- Anne E Urai
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: The experimental procedures were approved by Institutional committees at Cold Spring Harbor Laboratory (for experiments on rats), MIT and Harvard University (for mice auditory experiments) and were in accordance with National Institute of Health standards (project ID: 18-14-11-08-1). Experiments on mice visual decisions were approved by the home Office of the United Kingdom (license 70/8021). Experiments in humans were approved by the ethics committee at the University of Amsterdam (project ID: 2014-BC-3376).
Human subjects: The ethics committee at the University of Amsterdam approved the study, and all observers gave their informed consent.project ID: 2014-BC-3376
Copyright
© 2020, Lak et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 7,455
- views
-
- 1,134
- downloads
-
- 86
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Reinforcement biases subsequent perceptual decisions when confidence is low: a widespread behavioral phenomenon
eLife 9:e49834.
https://doi.org/10.7554/eLife.49834
Further reading
-
- Cell Biology
- Neuroscience
Reactive astrocytes play critical roles in the occurrence of various neurological diseases such as multiple sclerosis. Activation of astrocytes is often accompanied by a glycolysis-dominant metabolic switch. However, the role and molecular mechanism of metabolic reprogramming in activation of astrocytes have not been clarified. Here, we found that PKM2, a rate-limiting enzyme of glycolysis, displayed nuclear translocation in astrocytes of EAE (experimental autoimmune encephalomyelitis) mice, an animal model of multiple sclerosis. Prevention of PKM2 nuclear import by DASA-58 significantly reduced the activation of mice primary astrocytes, which was observed by decreased proliferation, glycolysis and secretion of inflammatory cytokines. Most importantly, we identified the ubiquitination-mediated regulation of PKM2 nuclear import by ubiquitin ligase TRIM21. TRIM21 interacted with PKM2, promoted its nuclear translocation and stimulated its nuclear activity to phosphorylate STAT3, NF-κB and interact with c-myc. Further single-cell RNA sequencing and immunofluorescence staining demonstrated that TRIM21 expression was upregulated in astrocytes of EAE. TRIM21 overexpressing in mice primary astrocytes enhanced PKM2-dependent glycolysis and proliferation, which could be reversed by DASA-58. Moreover, intracerebroventricular injection of a lentiviral vector to knockdown TRIM21 in astrocytes or intraperitoneal injection of TEPP-46, which inhibit the nuclear translocation of PKM2, effectively decreased disease severity, CNS inflammation and demyelination in EAE. Collectively, our study provides novel insights into the pathological function of nuclear glycolytic enzyme PKM2 and ubiquitination-mediated regulatory mechanism that are involved in astrocyte activation. Targeting this axis may be a potential therapeutic strategy for the treatment of astrocyte-involved neurological disease.
-
- Neuroscience
Alzheimer’s disease (AD) leads to progressive memory decline, and alterations in hippocampal function are among the earliest pathological features observed in human and animal studies. GABAergic interneurons (INs) within the hippocampus coordinate network activity, among which type 3 interneuron-specific (I-S3) cells expressing vasoactive intestinal polypeptide and calretinin play a crucial role. These cells provide primarily disinhibition to principal excitatory cells (PCs) in the hippocampal CA1 region, regulating incoming inputs and memory formation. However, it remains unclear whether AD pathology induces changes in the activity of I-S3 cells, impacting the hippocampal network motifs. Here, using young adult 3xTg-AD mice, we found that while the density and morphology of I-S3 cells remain unaffected, there were significant changes in their firing output. Specifically, I-S3 cells displayed elongated action potentials and decreased firing rates, which was associated with a reduced inhibition of CA1 INs and their higher recruitment during spatial decision-making and object exploration tasks. Furthermore, the activation of CA1 PCs was also impacted, signifying early disruptions in CA1 network functionality. These findings suggest that altered firing patterns of I-S3 cells might initiate early-stage dysfunction in hippocampal CA1 circuits, potentially influencing the progression of AD pathology.
